Azitra, Inc. (NYSE American: AZTR) Announces Major Corporate Actions Following 2026 Annual Meeting
BRANFORD, CT – June 15, 2026: Azitra, Inc. (NYSE American: AZTR), a biotechnology company, has filed a Form 8-K with the U.S. Securities and Exchange Commission disclosing significant corporate developments following its reconvened 2026 Annual Meeting of Stockholders.
Key Highlights and Shareholder Actions
- Increase in Authorized Common Stock:
- Shareholders approved an amendment to the Certificate of Incorporation, increasing the authorized number of common shares from 200,000,000 to 750,000,000.
- This move is aimed at providing the company with greater flexibility for potential future capital raises, acquisitions, stock-based compensation, and other corporate purposes.
- Reverse Stock Split Authorization:
- Shareholders authorized the Board to conduct one or more reverse stock splits at its discretion, which could be implemented to maintain listing requirements or improve share liquidity.
- Approval of Share Issuance Exceeding 19.99% Threshold:
- Stockholders approved proposals to issue more than 19.99% of currently outstanding shares, complying with NYSE American Company Guide Sections 713(a) and 713(b).
- This includes potential share issuances related to:
- Warrants under the securities purchase agreement with Alumni Capital LP (dated November 24, 2025).
- Conversion of Series A Preferred Stock and exercise of Series B and Series C Warrants under a securities purchase agreement (dated March 18, 2026).
- These approvals enable Azitra to raise capital through equity offerings, which may result in significant dilution depending on the structure and timing of such issuances.
- Ratification of Auditors:
- Grassi & Co., CPAs, P.C. was ratified as Azitra’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Stock Incentive Plan Proposal Not Approved:
- The proposal to amend and restate the Azitra, Inc. 2023 Stock Incentive Plan to increase the authorized share reserve was not approved by shareholders.
- This may impact the company’s ability to grant additional equity incentives to employees and management going forward.
- Adjournment Authorization:
- Shareholders approved the ability to adjourn the Annual Meeting if more time is needed to solicit votes for proposals.
Potential Price-Sensitive Implications for Investors
- Capital Structure Changes:
- The increase in authorized common shares and authorization for future share issuances could allow Azitra to raise additional capital but may result in significant dilution for existing shareholders if new shares are issued.
- Reverse Split Flexibility:
- The Board’s ability to implement a reverse split could affect the share price and trading volume. Reverse splits are often used to maintain exchange listing standards or address low share prices.
- Stock Incentive Plan Limitations:
- The failure to expand the stock incentive plan may limit Azitra’s ability to reward and retain talent through equity grants, potentially impacting operational performance and alignment of management incentives.
- Future Equity Issuances:
- Approvals for share issuances in excess of 19.99% suggest that Azitra may pursue further financing activities, which could be price-sensitive, especially depending on the terms and investors involved.
- Emerging Growth Company Status:
- Azitra remains an “Emerging Growth Company” as defined by SEC rules, which allows it to take advantage of certain reduced reporting and compliance requirements.
Additional Details
- The Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation, as filed on June 15, 2026, is available as Exhibit 3.1 of the 8-K filing.
- The company’s common stock remains listed on NYSE American under the trading symbol AZTR.
- More than one-third of outstanding shares were represented at the Annual Meeting, forming a quorum.
- The full text of the Certificate of Amendment and more details on each proposal are available in the company’s proxy statement filed on May 8, 2026, and incorporated by reference in the 8-K filing.
Summary for Investors
Azitra, Inc.’s latest 8-K report reveals major changes to its capital structure and flexibility for future financing, which are highly relevant for current and prospective shareholders. The potential for significant share dilution, reverse stock splits, and future equity offerings could materially impact the share price and investor returns. Shareholders and market participants should closely monitor Azitra’s future announcements regarding capital raises, reverse splits, and operational developments.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell securities. Investors should consult their own financial advisors and review official SEC filings and corporate disclosures before making any investment decisions. The information is based on public filings and may be subject to change or update.
